Stage III Ovarian Cancer AJCC v6 and v7 Recruiting Phase 0 Trials for MK-1775 (DB11740)

IndicationStatusPhase
DBCOND0093245 (Stage III Ovarian Cancer AJCC v6 and v7)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02659241Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal CancerBasic Science